Summary & Overview
CPT 82681: Free Estradiol Measurement by Equilibrium Dialysis
CPT code 82681 identifies a specialized laboratory assay for free estradiol, the unbound fraction of the estrogen estradiol measured commonly by equilibrium dialysis or comparable techniques. Free estradiol testing is clinically relevant for evaluating hormonal status related to ovarian function and conditions influenced by biologically active estradiol. Nationally, accurate reporting of this CPT code supports appropriate laboratory billing, diagnostic specificity, and clinical decision-making in endocrine and reproductive care.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines where coverage and coding alignment matter for laboratory services billed under this code. Readers will find a concise clinical context for the test, typical sites of service, and the operational implications of reporting CPT code 82681 in laboratory and outpatient settings. The summary addresses common modifiers and procedural considerations where available, and highlights benchmarks and policy-relevant points for payers and providers. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 82681 measures free estradiol—the fraction of estradiol not bound to proteins—using methods such as equilibrium dialysis on a serum specimen. The test quantifies biologically active estradiol and can better reflect the hormone's physiologic impact in conditions related to ovarian status.
Service type: Clinical laboratory test (special chemistry/endocrinology)
Typical site of service: Clinical laboratory or hospital outpatient laboratory
Clinical & Coding Specifications
Clinical Context
A 36-year-old woman with irregular menstrual cycles, symptoms of estrogen excess (breast tenderness, mood swings), and infertility evaluation presents to an outpatient women's health clinic. Her endocrinologist orders a serum free estradiol measurement using equilibrium dialysis to assess biologically active estradiol independent of binding proteins because total estradiol may be misleading in states with altered sex hormone–binding globulin (SHBG). The clinical workflow: the provider places the order in the electronic medical record, phlebotomy obtains a serum specimen at a scheduled outpatient laboratory draw (timed to cycle day when indicated), the specimen is sent to a clinical chemistry laboratory capable of performing equilibrium dialysis and free estradiol assay, the laboratory performs the equilibrium dialysis and reports the 82681 result to the ordering provider via the laboratory information system, and the clinician integrates the free estradiol value with total estradiol, SHBG, and clinical findings to inform diagnosis and management of ovarian function or estrogen-related disorders.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation component if the laboratory test includes a professional component in rare consultative settings. |